Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jamie Timmons
Observed name:
J Timmons
Institution:
Amylyx Pharmaceuticals, Inc. (United States)
Observed institution:
Amylyx Pharmaceuticals, Inc. (United States)
OpenAlex ID:
A5004158980
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
2022
·
Sabrina Paganoni
, Claire Watkins
, et al.
·
Muscle & Nerve
·
50
PDF
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trial
2023
·
Robert Bowser
, Jiyan An
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
24
PDF
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls
2023
·
Sabrina Paganoni
, Melanie Quintana
, et al.
·
Annals of Clinical and Translational Neurology
·
21
PDF
Phosphorylated Tau at Threonine 181 Is Elevated in Amyotrophic Lateral Sclerosis Plasma
2026
·
Tiziana Petrozziello
, Evan Mizerak
, et al.
·
Muscle & Nerve
·
3
PDF
Safety of a Fixed-Dose Coformulation of Sodium Phenylbutyrate and Taurursodiol in Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: Integrated Clinical Trials Experience (S11.005)
2022
·
Steven E. Arnold
, Sabrina Paganoni
, et al.
·
Neurology
·
2
A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Post-Bariatric Hypoglycemia (LUCIDITY)
2025
·
Ryan Miller
, Marilyn Tan
, et al.
·
Metabolism
·
1
P.094 A phase 1, multicenter, randomized, placebo-controlled, multiple ascending dose study to evaluate the safety and tolerability of AMX0114 in ALS (LUMINA)
2025
·
S Paganoni
, L Kett
, et al.
·
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)
2023
·
Sabrina Paganoni
, Melanie Quintana
, et al.
·
Neurology
P.049 Determining individual substantial response in amyotrophic lateral sclerosis: utilizing a new method on CENTAUR trial results
2022
·
T Jason
, L Mehta
, et al.
·
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Show more works
View as search
Works count:
9
Citation count:
101
H-index:
3
I10-index:
3
Year
Topic
Type